TNF and inflammatory bowel disease: A study in patients with IBD [38] recently reported that biological therapy (including anti-TNFα) in patients vaccinated with two doses of BNT162b2 (Pfizer) led to reduced anti-S levels compared to HCs vaccinated with two doses of the mRNA 1273 (Moderna).